This Hackathon is a Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) – Virtual Research Institute (JPIAMR-VRI) activity supported and co-organised with the following groups:
Joint Programming Initiative on Antimicrobial Resistance (JPIAMR)
The Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) is a global collaborative platform and has engaged 27 nations to curb antibiotic resistance (AMR) with a One Health approach. The initiative coordinates national funding to support transnational research and activities within the six priority areas of the shared JPIAMR Strategic Research and Innovation Agenda – therapeutics, diagnostics, surveillance, transmission, environment and interventions. The JPIAMR is currently developing a platform to extend shared research capabilities on a global scale through the Virtual Research Institute (JPIAMR-VRI).
Swedish Research Council
The Swedish Research Council is a government agency within the Ministry of Education and Research. We fund research and research infrastructure in all scientific disciplines. We are also advisors to the Government on research policy issues and work to increase understanding of the long-term societal benefits of research.
The Swedish Research Council is Sweden’s largest governmental research funding body, and supports research of the highest quality within all scientific fields. Every year, we pay out almost 7 billion SEK to support Swedish research.
Institute of Infection and Immunity (III) of the Canadian Institutes of Health Research (CIHR)
At the Canadian Institutes of Health Research (CIHR) we know that research has the power to change lives. As Canada's health research investment agency, we collaborate with partners and researchers to support the discoveries and innovations that improve our health and strengthen our health care system.
The CIHR Institute of Infection and Immunity (CIHR-III) invests in research on infectious diseases and the body's immune system. Through this research, III addresses a wide range of health concerns related to infection and immunity, including disease prevention and treatment, as well as public health promotion.
Research Council of Norway
The Research Council works to promote research and innovation of high quality and relevance. We help to generate knowledge in priority areas to enable Norway to deal with key challenges to society and the business sector.
We administer the country’s largest competitive arena for allocation of public R&D funding on behalf of the Norwegian Government, and invest approximately NOK 10 billion in research and innovation projects each year. This funding comes from 18 different government ministries.
Our task is to establish sound funding distribution mechanisms that promote development in research environments, trade and industry and the public sector, and ensure that this funding is allocated to the best applicants.
Collaborators and Consultants
Uppsala Antibiotic Center (UAC)
The UAC is a center that aims to bring together, stimulate and support important research on antibiotic resistance from all three disciplinary domains at Uppsala University: Medicine and Pharmacy, Science and Technology, and Humanities and Social Sciences.
The basis of UAC is the broad and internationally renowned research and higher education within the field of antibiotics and resistance at UU and the existing prerequisites to unite interdisciplinary actors to find innovative solutions. The center is specialized in research, innovation and international outreach.
In addition to the emphasis on building a community involving PhD students, supervisors and the research school, UAC arranges workshops, seminar series and other means for partnerships to build an extensive interdisciplinary environment for antibiotic research and communication.
Hacking Health Foundation
Hacking Health Foundation is a Montreal-based non-profit organization whose mission is to foster and accelerate innovation in healthcare by empowering key stakeholders and communities to create innovative and meaningful solutions to real-world challenges.
Hacking Health catalyzes collaboration by first building an innovation ecosystem which includes patients, healthcare institutions, academia, professional associations, tech hubs, government, corporations and investors. We then bring them together via our many platforms to collaborate and co-create.
Since its inception in 2012, Hacking Health has assembled over 15,000 people producing more than 1,700 solutions and start-ups, ultimately transforming cities and institutions. What started as a volunteer grassroots movement that has evolved into an international organization embedded within the Centre Hospitalier d’Université de Montréal's (CHUM).
In the face of increasingly complex health issues, we engage all stakeholders inside and outside the healthcare sector. By facilitating cross-disciplinary collaborations, we help generate fresh insights and creative solutions to current challenges. We find new ways to make the best ideas emerge and generate lasting impact.
AMR DxC - The Antimicrobial Resistance Diagnostics Challenge competition
AMR DxC is an initiative founded by Prof. Till Bachmann and hosted at the University of Edinburgh. AMR DxC's mission is to connect and inspire the next generation of talent to seed diagnostic innovation globally. AMR DxC aims to create a truly global, multidisciplinary, entrepreneurial and implementable route to develop new AMR diagnostics where they are needed most - independent of the location of the innovator. AMR DxC runs international diagnostics schools since 2015.
Till Bachmann is the Professor of Molecular Diagnostics and Infection as well as Deputy Head of Infection Medicine at Edinburgh Medical School. Till has a strong educational track record as Programme Director of the online Clinical Microbiology & Infectious Diseases MSc and Director of the Zhejiang University-University of Edinburgh Institute Dual PhD programme. He fulfils industrial and institutional advisory roles worldwide including the Longitude Prize. Till is the Vice Chair or the JPIAMR Scientific Advisory Board, member of the JPIAMR-VRI task force and coordinator of the JPIAMR funded network AMR Dx Global. Till will also be a Mentor at Hacking AMR 2019.
LYO-X is providing Quantitative Systems Pharmacology (QSP) and mathematical PK/PD modelling services for the biotechnology and pharmaceutical industry. LYO-X’s main expertise is the pharmacology of biotherapeutics and novel therapeutic formats including antibodies, bi-specifics, antibody-drug conjugates (ADCs), fusion proteins, peptides, gene therapies and siRNAs. LYO-X is well recognized as one of the few providers worldwide in this niche domain and to date has been supporting over 100 companies globally in translating their highly innovative therapeutic molecules to patients. LYO-X supports compound design and selection, PK/PD studies, toxicology studies, early translation of PK and PD from animal to human including first in human dose estimation and clinical dose selection. We also support dose finding studies and phase III studies with population PK/PD modelling and clinical trial simulations. The disease areas in which we have an in-depth expertise are infectious diseases, immuno-oncology, ophthalmology, autoimmune and inflammatory diseases, metabolic diseases and rare diseases.